<?xml version="1.0" encoding="UTF-8"?>
<p>The clinical trial will enroll up to 510 participants and will be led by the Jenner Institute and the Vaccinology Group of the University of Oxford. The study started in March 2020 and is scheduled to be completed in May 2021. It will be conducted in the UK, on healthy adult volunteers aged 18â€“55. The vaccine will be administered intramuscularly.</p>
